Your browser doesn't support javascript.
loading
Ectopic ACTH Syndrome - Experience with etomidate / Journal of the ASEAN Federation of Endocrine Societies
Article in En | WPRIM | ID: wpr-997843
Responsible library: WPRO
ABSTRACT
@#For ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS), when surgery is not feasible, or in cases of severe biochemical disturbances, immunosuppression or mental instability, medical therapy with agents such as etomidate is indicated. We present our experience in using etomidate for a 41-year old female with EAS secondary to a malignant mediastinal paraganglioma. We were able to demonstrate that etomidate can be used effectively to control severe hypercortisolism in a lower dose than previously described.
Subject(s)
Key words
Search on Google
Index: WPRIM Main subject: ACTH Syndrome, Ectopic / Etomidate Language: En Journal: Journal of the ASEAN Federation of Endocrine Societies Year: 2017 Type: Article
Search on Google
Index: WPRIM Main subject: ACTH Syndrome, Ectopic / Etomidate Language: En Journal: Journal of the ASEAN Federation of Endocrine Societies Year: 2017 Type: Article